|
Couple thing to keep in mind. So far, we haven't figured out how to provide a wide and deep net of coverage. In the US, we have the deepest coverage available (US responsible for 70% of new drugs invented, advances in devices, etc), but have a narrow coverage (fewer people can attain these products/services).
In Canada/EU/UK, they have a wide net, but very shallow services (especially if you are old). But, everyone is covered.
Maybe we should have a hybrid? Wide coverage of basic services (public $'s) , with the ability to supplement w/private plans.
Also, what people forget is that innovation (the at risk $ that is invested to bring new drugs/therapies to market) can be severely hampered if we restrict profit in the system. The investors will simply shift their investments to other industries with a better risk/reward profile. Money is fungible, and easily diverted.
Tough choices all around.
|
06-08-2009, 07:22 PM
Threaded Mode
